Avantor, Inc. (AVTR)
NYSE: AVTR · Real-Time Price · USD
11.36
-2.08 (-15.48%)
At close: Aug 1, 2025, 4:00 PM
11.45
+0.09 (0.79%)
After-hours: Aug 1, 2025, 7:59 PM EDT
United States Steel Market Cap
Avantor has a market cap or net worth of $7.74 billion as of August 1, 2025. Its market cap has decreased by -47.07% in one year.
Market Cap
7.74B
Enterprise Value
11.53B
1-Year Change
-47.07%
Ranking
Category
Stock Price
$11.36
Market Cap Chart
Since May 17, 2019, Avantor's market cap has increased from $4.93B to $7.74B, an increase of 57.10%. That is a compound annual growth rate of 7.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 9.16B | -36.14% |
| Dec 31, 2024 | 14.34B | -7.13% |
| Dec 29, 2023 | 15.44B | 8.60% |
| Dec 30, 2022 | 14.22B | -44.64% |
| Dec 31, 2021 | 25.68B | 57.75% |
| Dec 31, 2020 | 16.28B | 56.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 17, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 664.39B |
| Johnson & Johnson | 396.75B |
| AbbVie | 333.89B |
| AstraZeneca | 232.21B |
| UnitedHealth Group | 226.39B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 219.63B |
| Novo Nordisk | 213.92B |